e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Asthma: control and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of heated heliox-driven nebulizer therapy on pulmonary hypertension and arterial oxygenation of patients with bronchial asthma
H. Loshkareva, S. Grigoriev, O. Aleksandrov (Moscow, Russian Federation)
Source:
Annual Congress 2011 - Asthma: control and treatment
Session:
Asthma: control and treatment
Session type:
Thematic Poster Session
Number:
884
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Loshkareva, S. Grigoriev, O. Aleksandrov (Moscow, Russian Federation). The influence of heated heliox-driven nebulizer therapy on pulmonary hypertension and arterial oxygenation of patients with bronchial asthma. Eur Respir J 2011; 38: Suppl. 55, 884
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Selection of the optimal nebulizer for further clinical development of inhaled nebulized nitrite (AIR001) in pulmonary arterial hypertension patients
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Effects of nebulised iloprost on pulmonary function and oxygenation in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002
Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension
Source: Eur Respir J 2001; 17: 14-19
Year: 2001
Effects of inhaled salbutamol in primary pulmonary hypertension
Source: Eur Respir J 2002; 20: 524-528
Year: 2002
Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
Influence of heliox upon pulmonary haemodynemics in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 238s
Year: 2001
Experience with inhaled iloprost in paediatric pulmonary arterial hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Effects of continuous positive airway pressure (nCPAP) on pulmonary hemodynamics in COPD patients with overlap syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 568s
Year: 2004
Oral sildenafil is a potent pulmonary vasodilator and improves gas exchange in patients with COPD with pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 426s
Year: 2006
Influence of inhaled iloprost on transpulmonary gradient of big-endothelin in patients with pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002
Acute response of iloprost inhalation using the Breelib nebulizer in pulmonary arterial hypertension: the Breelib acute study
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Effect of salbutamol on arterial blood gas tensions in patients with stable hypercapnic chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 16s
Year: 2004
Biphasic cuirass ventilation decreased the indices of pulmonary circulation in patients with secondary pulmonary hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Effect of NPPV on pulmonary arterial hypertension in patients with hypercapnic respiratory failure
Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation
Year: 2007
Use of heated heliox-driven nebulizer therapy in the treatment of patients with bronchial asthma
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Pulmonary hypertension at the patients with bronchial asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 58s
Year: 2004
Long-term improvement of pulmonary haemodynamics and exercise capacity in patients with pulmonary hypertension and hypoventilation following NIPPV and influence of NIPPV adherence
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Inhaled treprostinil therapy in patients with pulmonary hypertension and parenchymal lung disease
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
Systemic inflammation and pulmonary hypertension in patients with bronchial asthma
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Influence of natural lung surfactant inhalations on clinical symptoms and pulmonary function parameters in patients with bronchial asthma
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept